Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors-Reference-Cited by-同舟云学术

Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors

Published:2020-11-12 Issue:2 Volume:46 Page:415-423
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Hsu Chia‐Yun¹,Chen Wen‐Jone²,Chen Ho‐Ming¹,Tsai Hsin‐Yi³,Hsiao Fei‐Yuan⁴⁵⁶^ORCID

Affiliation:

1. Health Data Research Center National Taiwan University Taipei Taiwan

2. Division of Cardiology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

3. Value, Access and Policy Amgen Taiwan Limited Taipei Taiwan

4. Graduate Institute of Clinical Pharmacy College of Medicine National Taiwan University Taipei Taiwan

5. School of Pharmacy National Taiwan University Taipei Taiwan

6. Department of Pharmacy National Taiwan University Hospital Taipei Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13299

Reference37 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

3. Lipid‐lowering for peripheral arterial disease of the lower limb;Aung PP;Cochrane Database Syst Rev,2007

4. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review;Pharmacoepidemiology and Drug Safety;2024-08

2. Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators;Journal of Diabetes Investigation;2024-04-27

3. Validation of Stroke Risk Factors in Patients with Acute Ischemic Stroke, Transient Ischemic Attack, or Intracerebral Hemorrhage on Taiwan’s National Health Insurance Claims Data;Clinical Epidemiology;2022-03